Elacestrant
About
Therapy type: Hormone therapy
Therapy strategy: ER signaling inhibition
Mappings
NCI Thesaurus: Elacestrant (ncit:C120211)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | ER positive, ESR1 oncogenic variants, HER2-negative | Invasive Breast Carcinoma | Elacestrant | |
| Sensitivity (+) | ER positive, ESR1 oncogenic variants, HER2-negative | Invasive Breast Carcinoma | Elacestrant | |
| Sensitivity (+) | FGFR2::v | Intrahepatic Cholangiocarcinoma | Elacestrant | |
| Sensitivity (+) | FGFR2 rearrangements | Intrahepatic Cholangiocarcinoma | Elacestrant |